Related Experiment Video
Updated: May 15, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Multiple ventricular septal defects and severe tricuspid regurgitation in an infant - a case report and surgical
Neerod Kumar Jha1,2, Aleksandr Omelchenko3, Ashutosh Goyal4
1Division of Paediatric Cardiac Surgery, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates. nk_jha@hotmail.com.
Insights
A minimally invasive perventricular device closure was successfully used to treat an infant with complex ventricular septal defects and severe tricuspid regurgitation. This approach offers a safer alternative for high-risk infants with congenital heart disease.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease
- Minimally Invasive Surgery
Background:
- Ventricular septal defect (VSD) is the most common congenital heart disease.
- Multiple VSDs, termed "Swiss Cheese" variant, present complex surgical challenges.
- Severe tricuspid regurgitation and elevated right ventricular pressure increase surgical risks.
Purpose of the Study:
- To present a case of complex VSD in an infant with Holt-Oram syndrome.
- To evaluate a minimally invasive approach for high-risk infants.
- To demonstrate the feasibility of perventricular device closure.
Main Methods:
- Case presentation of a six-month-old infant with congestive heart failure and Holt-Oram syndrome.
- Echocardiography and chest x-ray confirmed diagnosis of multiple VSDs and severe tricuspid regurgitation.
- Peventricular device closure was chosen due to high risks associated with traditional surgical options.
Main Results:
- The infant presented with symptoms of congestive heart failure, poor weight gain, and hepatomegaly.
- Medical management failed, necessitating surgical intervention.
- Minimally invasive perventricular device closure was performed successfully.
Conclusions:
- Minimally invasive perventricular device closure is a viable option for infants with complex VSDs, severe tricuspid regurgitation, and genetic disorders.
- This approach can avoid the risks associated with traditional surgical methods.
- It offers potentially better outcomes for high-risk pediatric patients.
Background:
Ventricular septal defect is the most prevalent form of congenital heart disease, occurring as isolated lesion in approximately 20% of cases and as part of more complex malformations in up to 40%. Multiple ventricular septal defects are usually associated with "Swiss Cheese" variant characterized by multiple perforations throughout the muscular septum, often involving the apical, mid-muscular, and anterior regions, which creates a complex network of left-to-right shunts that are technically difficult to identify and close individually. Presence of severe tricuspid regurgitation contributes to risks related to poor prognosis. An infant with congestive heart failure, severe tricuspid regurgitation, large left-to-right shunting and elevated right ventricular pressure requires a critical decision-making process for surgical management due to higher risks and poor outcome.
Case Presentation:
We are presenting herewith a six-month-old infant with Holt-Oram syndrome, who presented with classic signs of congestive heart failure, tachypnoea, poor weight gain and hepatomegaly, all indicative of systemic and pulmonary venous congestion. Chest x-ray and echocardiography confirmed the diagnosis. Despite aggressive medical management the patient's condition continued to deteriorate and required surgical intervention. The traditional management paradigm for such infants involves a choice between palliative pulmonary artery banding or surgical closure. In this case, both options presented significant risks and were deemed suboptimal. Therefore, to avoid risks, we opted a minimal invasive perventricular device closure of the defects with success.
Conclusions:
Children with severe tricuspid regurgitation, right ventricular failure, Swiss cheese morphology, multiple ventricular septal defects, genetic disorders and low weight may be considered for minimal invasive approaches including perventricular device closure of the ventricular septal defects whenever feasible to avoid operative risks and offer better outcomes.
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management

